SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's has become the latest focal point for retail investors, experiencing extreme volatility and heavy volume driven by speculation of a potential short squeeze. Community members are actively sharing their positions and coordinating efforts to hold shares, drawing parallels to past meme stock rallies while reacting to multiple trading halts.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending amid significant investor volatility, fueled by persistent community concerns over share dilution and the stock's decoupling from Bitcoins price action. Investors are actively debating whether the current pullback to long-term support levels represents a generational buying opportunity or the beginning of a deeper structural decline.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is currently experiencing intense volatility as investors weigh the impact of shifting macroeconomic data against persistent structural demand from the solar and AI hardware sectors. Community discussions are highly polarized, with many retail traders frustrated by the asset's price sensitivity to interest rate expectations and broad liquidity tightening, while long-term advocates emphasize that record industrial consumption creates a fundamental floor for future appreciation.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is facing extreme volatility as investors weigh a strong revenue beat and multi-billion dollar partnerships against concerns regarding shrinking margins and upcoming insider share lockup expirations. The community remains deeply divided, with some betting on a rapid recovery fueled by AI hardware demand while others anticipate a sharp correction as they scrutinize the stock's valuation and potential selling pressure.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is surging as investors react to high-profile executive orders prioritizing quantum technology, with community sentiment boosted by the CEO's direct participation in White House policy discussions. Traders are actively debating whether this momentum will trigger a sustained breakout, focusing heavily on potential institutional index inclusion and upcoming technical product updates.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors react to a significantly expanded 4 GW project pipeline, with management highlighting massive interest from AI-driven data centers for their on-site power solutions. While the stock remains volatile due to ongoing earnings losses and shareholder dilution concerns, the community is actively debating the company's ability to convert these proposals into firm, revenue-generating contracts.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing heightened investor activity and volatility as the community eagerly awaits trailer reveals and the commencement of pre-orders for the highly anticipated Grand Theft Auto VI. Traders are closely monitoring the upcoming earnings report, with sentiment split between optimism over the November launch window and concerns regarding forward-looking guidance and potential launch delays.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

The SPDR Gold Shares ETF is experiencing significant volatility as market participants debate whether recent price action represents a tactical reset or a deeper trend reversal amid shifting Federal Reserve rate expectations and geopolitical uncertainty. Investors are heavily focused on the interplay between inflation data, the strength of the U.S. dollar, and ongoing institutional gold buying as the community debates whether the asset's role as a hedge is currently being undermined by broader market liquidations.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is experiencing a significant surge following an agreement with Renew Home and Tesla to develop a large-scale virtual power plant, which the community sees as a major catalyst for grid infrastructure and AI-driven energy demand. Investors are actively discussing the stock's high short interest as a potential tailwind for further upward momentum and price discovery.

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Absci Corp

Absci Corp is gaining significant attention due to positive clinical updates on its antibody candidate for hair loss and a fresh injection of capital from major healthcare investors. The community is actively debating the potential for a short squeeze given the stock's high short interest and the strategic participation of industry heavyweights like Eli Lilly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer

IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's...

Brains, AI Imaging, and Breakthrough Antibiotics Ignite Investor Buzz

The healthcare and biotechnology sector continues to generate a steady stream of meaningful catalysts as companies advance novel therapies, secure regulatory milestones, strengthen intellectual property portfolios, and expand commercialization efforts. Recent developments from CervoMed (NASDAQ:CRVO), Butterfly Network (NYSE:BFLY), NeOnc (NASDAQ:NTHI), Spero Therapeutics (NASDAQ:SPRO), GSK (NYSE:GSK), and IceCure Medical (NASDAQ:ICCM) highlight several emerging themes shaping the sector, including neurodegenerative disease treatment, AI-powered diagnostics, antimicrobial resistance, minimally invasive cancer care, and synthetic biology.

Smartbird, Nebius Group, IceCure Medical, Robinhood And Meta: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. stock indexes closed lower on Wednesday, with the Dow Jones Industrial Average slipping 0.98% to 51,942.55.read more...

IceCure Lands Financing following this Morning's Breast Cancer Treatment Adoption Announcement

IceCure Medical (NASDAQ:ICCM) captured investor attention after reporting, this morning, strong commercial momentum following FDA marketing authorization of its ProSense breast cancer cryoablation platform, as the company announced a 70% increase in its active U.S. commercial install base since receiving FDA clearance in October 2025.

IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor

IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused...

ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally?

Equity

IceCure reported a 70% increase in its active U.S. commercial install base of ProSense systems. 


Technological Innovations to Wage War Against Some of Medicine's Toughest Diseases

The biotechnology space is delivering a steady stream of potentially market-moving developments this week as companies across oncology, neuroscience, gene therapy, medical devices, and synthetic biology delivered significant regulatory, clinical, and commercial updates. $NTHI, $QURE, $ICCM, $CLPT, $ELTX, $AZTR

IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance PR Newswire CAESAREA, Israel, June 17, 2026 Increase...

IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance PR Newswire CAESAREA, ISRAEL, June 2, 2026 Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital...

IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked

IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO...

IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Icecure Medical Ltd

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.52	--	--	N/A
Q1 '26	-$0.05	-$1.80	-3757.12%	MISSED
Q4 '25	-$0.05	--	--	N/A
Q3 '25	-$0.05	-$0.06	-27.40%	MISSED
Q2 '25	-$0.06	-$0.06	6.88%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

ICCMIcecure Medical Ltd

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ICCM News